This suggests that a subgroup of individuals with obesity and T2D are characterized by additional alterations in lipid metabolism, which may be reflected or mediated by adipokines including SFRP5, RBP4, CTRP3 and 5, omentin and adiponectin. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.